﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>BioSpectrum Asia - RSS Feed</title>
    <link>http://biospectrumasia.ciol.com/rss/</link>
    <description>BioSpectrum Asia is a specialized information platform for life science articles in the Asia Pacific that includes life sciences articles, pharma news, life science products reviews and other information</description>
    <language>en-us</language>
    <pubDate>3/15/2010 5:30:34 PM</pubDate>
    <lastBuildDate>3/15/2010 5:30:34 PM</lastBuildDate>
    <docs>http://biospectrumasia.ciol.com/rss/</docs>
    <generator>BSA Feed Generator</generator>
    <managingEditor>sureshn@cybermedia.co.in</managingEditor>
    <webMaster>webmasterciol@cybermedia.co.in</webMaster>
    <item>
      <title>Nanobiotechnology will gain prominence in stem cell research, says Dr Samuel JK Abraham</title>
      <link>http://www.biospectrumasia.com/content/150310IND12239.asp</link>
      <description>Nichi-In Center for Regenerative Medicine (NCRM), based in Chennai, is an Indo-Japan joint venture institute that carries out research, training and clinical applications-protocol development in regenerative medicine, with emphasis on stem cells</description>
      <pubDate>3/15/2010 3:49:13 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310IND12239.asp</guid>
    </item>
    <item>
      <title>Bayer to up employee numbers in India, Vietnam</title>
      <link>http://www.biospectrumasia.com/content/150310IND12238.asp</link>
      <description>German drug behemoth Bayer Schering is strengthening its employee base in India and Vietnam to gain market share in two of Asia''s fastest growing pharma markets</description>
      <pubDate>3/15/2010 3:33:35 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310IND12238.asp</guid>
    </item>
    <item>
      <title>Ranbaxy, Takeda tie up to resolve patent litigation</title>
      <link>http://www.biospectrumasia.com/content/150310IND12237.asp</link>
      <description>Ranbaxy Laboratories and has reached an agreement with Takeda Pharmaceutical Company and Takeda Pharmaceuticals North America, for resolving outstanding patent litigation related to Ranbaxy''s generic equivalent version of Actos</description>
      <pubDate>3/15/2010 3:14:06 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310IND12237.asp</guid>
    </item>
    <item>
      <title>HGS, BioInvent to co-develop therapeutic antibodies</title>
      <link>http://www.biospectrumasia.com/content/150310OTH12236.asp</link>
      <description>Human Genome Sciences (HGS) and BioInvent International have entered into a collaboration to discover, develop and commercialize therapeutic monoclonal antibodies that specifically target antigens discovered by HGS</description>
      <pubDate>3/15/2010 3:02:00 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310OTH12236.asp</guid>
    </item>
    <item>
      <title>Caraco to market generic eloxatin</title>
      <link>http://www.biospectrumasia.com/content/150310IND12235.asp</link>
      <description>Caraco Pharmaceutical, the American subsidiary of India''s Sun Pharma has launched oxaliplatin injections after receiving US FDA nod</description>
      <pubDate>3/15/2010 2:59:15 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310IND12235.asp</guid>
    </item>
    <item>
      <title>Fortis acquires stake in Singapore''s Parkway Holdings</title>
      <link>http://www.biospectrumasia.com/content/150310IND12234.asp</link>
      <description>Indian healthcare company, Fortis Healthcare, has acquired 23.9 percent strategic stake in Parkway Holdings, Singapore. Parkway is one of Asias premium healthcare providers, with a network of 16 hospitals having 3,400 beds spread over six countries,</description>
      <pubDate>3/15/2010 12:08:42 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310IND12234.asp</guid>
    </item>
    <item>
      <title>Pfizer discontinues another Figitumumab trial</title>
      <link>http://www.biospectrumasia.com/content/150310OTH12233.asp</link>
      <description>Pfizer has discontinued phase III trial of its monoclonal antibody A4021018 for non small cell lung cancer</description>
      <pubDate>3/15/2010 11:57:07 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310OTH12233.asp</guid>
    </item>
    <item>
      <title>Novartis'' diabetes trials successful</title>
      <link>http://www.biospectrumasia.com/content/150310OTH12232.asp</link>
      <description>Novartis said studies involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type II diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance</description>
      <pubDate>3/15/2010 11:26:26 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310OTH12232.asp</guid>
    </item>
    <item>
      <title>TaiGen''s DFI drug meets primary endpoint in phase II</title>
      <link>http://www.biospectrumasia.com/content/150310TWN12231.asp</link>
      <description>Taiwan''s TaiGen Biotechnology said that the phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability</description>
      <pubDate>3/15/2010 10:59:07 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/150310TWN12231.asp</guid>
    </item>
    <item>
      <title>Person of the Year: Dr. Brian McNamee</title>
      <link>http://www.biospectrumasia.com/content/120310AUS12230.asp</link>
      <description>In a career spanning three decades he has met challenges head on. The latest being CSL developing Panvax to curtail the global threat of swine flu</description>
      <pubDate>3/12/2010 6:47:23 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/120310AUS12230.asp</guid>
    </item>
    <item>
      <title>Affymax gets $5mn milestone payment from Takeda</title>
      <link>http://www.biospectrumasia.com/content/120310JPN12229.asp</link>
      <description>American pharma company Affymax has received a $5 mn development milestone payment from Japan''s Takeda Pharmaceutical</description>
      <pubDate>3/12/2010 2:37:30 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/120310JPN12229.asp</guid>
    </item>
    <item>
      <title>SRL launches Sports Gene Test for the first time in India</title>
      <link>http://www.biospectrumasia.com/content/120310IND12228.asp</link>
      <description>Super Religare Laboratories (SRL), one of Indias largest diagnostics networks, has become the first in the country to launch the Sports Gene Test that would help parents know which sport their child is most suited for</description>
      <pubDate>3/12/2010 1:05:15 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/120310IND12228.asp</guid>
    </item>
    <item>
      <title>Bilcare research opens new unit at Crickhowell</title>
      <link>http://www.biospectrumasia.com/content/120310IND12227.asp</link>
      <description>Bilcare Global Clinical Supplies, a clinical trial services provider will open its second unit in The Elvicta Industrial Estate, Crickhowell, Wales, UK. The new unit will add 30,000 sq.ft. and double the company''s European capacity</description>
      <pubDate>3/12/2010 1:01:18 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/120310IND12227.asp</guid>
    </item>
    <item>
      <title>Ricerca Biosciences finalizes acquisition of MDS Pharma service business</title>
      <link>http://www.biospectrumasia.com/content/120310OTH12226.asp</link>
      <description>Ricerca Biosciences has finalized the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan</description>
      <pubDate>3/12/2010 12:52:11 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/120310OTH12226.asp</guid>
    </item>
    <item>
      <title>Australian audiology firm launches India operations</title>
      <link>http://www.biospectrumasia.com/content/120310IND12225.asp</link>
      <description>Leading Australian audiology service provider, NHC Group launched its operations in India. The Indian operation  NHC Hearing Care was launched on March 11, 2010</description>
      <pubDate>3/12/2010 12:17:20 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/120310IND12225.asp</guid>
    </item>
  </channel>
</rss>